Search Results 651-660 of 17876 for monoclonal antibody

1. Mayo Clinic Q&A podcast: Covering COVID-19 in 2021

   Now we have three vaccines in the U.S., and antiviral and monoclonal antibody treatments. That's really incredible." Despite the rapid scientific ...

2. A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma - Mayo Clinic

   History of Grade 4 anaphylactic reaction to any monoclonal antibody therapy. 15. Certain treatment with investigational agents and other anti-neoplastic ...

3. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

4. Bullous Pemphigoid Clinical Trials - Mayo Clinic Research

   Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

5. Tonsil Cancer Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

6. Hematology - Clinical trials

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the growth ...

7. Study of Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder - Mayo Clinic

   Monoclonal antibodies, such as rituximab may block tumor growth in different ways by targeting certain cells. LMP-specific T-cells are special immune system ...

8. Doxorubicin Hydrochloride, Cyclophosphamide, And Paclitaxel With Or Without Bevacizumab In Treating Patients With Lymph Node-Positive Or High-Risk, Lymph Node-Negative Breast Cancer - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Bevacizumab may also stop the growth of breast ...

9. Autoimmune encephalitis: Paving the way to better outcomes - Mayo Clinic

   Mayo Clinic is exploring the potential benefit of inebilizumab, a monoclonal antibody recently approved for the treatment of neuromyelitis optica spectrum ...

10. A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152) (SKYSCRAPER-14) - Mayo Clinic

    About this study. The purpose of this study is to assess the efficacy and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when administered in ...